$WOK

HRT FINANCIAL LP purchased $26K of WOK

HRT FINANCIAL LP purchased 268,927 shares of WORK Medical Technology Group LTD (WOK) at $0.10 on 2026-06-15.

Original reporting
SEC EDGAR · HRT FINANCIAL LP
Published Jun 17, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$WOK
Bullish
medium confidence
Mentioned
$WOK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WOKBullishLow
01

Why it matters

The disclosure provides a fresh datapoint on ownership and potential sentiment, but it does not include any new operating or financial information that would typically drive repricing.

02

Market read

Traders may treat the buy as a small positive sentiment signal, but the transaction size and lack of fundamental catalysts suggest limited trading impact.

03

What to watch

No 10b5-1 plan is cited; however, the filing alone doesn’t reveal intent, timing constraints, or whether other insiders/owners are selling concurrently.

Relevance 4/10Novelty 6/10Timing: filed 2026-06-17 (transaction dated 2026-06-15)

Background

The article is an SEC Form 4 insider transaction disclosure: HRT Financial LP (10% owner) reported an open-market purchase in WORK Medical Technology Group LTD.

Company-level read

Ticker impact

$WOKBullishMedium confidence
Context

HRT Financial LP, a 10% owner, filed a Form 4 showing an open-market purchase of 268,927 shares at $0.0950 on 2026-06-15.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is primary-source and time-stamped, but it discloses a relatively small transaction ($25.5k) with no accompanying company-specific news (earnings, contract, trial, or guidance).

Market effects

No sector read-across; this is a single-issuer ownership transaction.

None indicated.

None indicated.

Counterpoint

A 10% owner buy can be routine (liquidity management or plan-related) and may not reflect a change in fundamentals, especially given the small dollar amount.

Key entities

  • WORK Medical Technology Group LTD

    Subject of the Form 4; received disclosure of a 10% owner open-market purchase.

  • HRT Financial LP

    10% owner reporting an open-market purchase of 268,927 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FDMTMed

Top Biotech Gainers: FDMT, OABI, ACXP Rally On Pipeline And Regulatory News

Biotech gainers were led by 4D Molecular Therapeutics (FDMT), up over 12%, after Phase 3 enrollment progress for 4D-150 in wet AMD and other pipeline updates, plus a $200M credit facility. OmniAb (OABI) rose over 11% on an Eli Lilly collaboration and higher 2026 cash guidance. Acurx (ACXP) gained over 14% after FDA conditional acceptance of CIFBEZY as ibezapolstat’s brand name.